NEW Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Research, Clinical Care and Training

EXPLORE THE FIELD · RESEARCH AND EVIDENCE

The scientific
foundation of
metabolic psychiatry.

Growing evidence is establishing the positive effects metabolic psychiatry approaches have on mental health outcomes. The field is positioned to explore the underlying mechanisms, advance the science, and expand real-world implementation.

MetPsy – metabolic psychiatry.

AN EMERGING FIELD

Mental health begins
with metabolism.

Metabolic psychiatry investigates mental health through the lens of cellular energy and brain metabolism. Drawing on a century of evidence, researchers are exploring metabolic interventions as therapeutic strategies for complex psychiatric conditions. Rather than replacing existing care, these therapies offer new, evidence-based perspectives and tools for treatment. Critical research continues to examine the shared links between mental illness and issues like neuroinflammation, mitochondrial dysfunction, and insulin resistance.






Type Year Sorted oldest first. Sort newest first. Authors Diagnosis Title & summary
Reviews 2020 Sarnyai Z, Palmer CM Schizophrenia Ketogenic Therapy in Serious Mental Illness: Emerging Evidence (opens in a new tab)

A commentary reviewing the emerging evidence supporting the use of nutritional ketosis as a treatment for serious mental illness.

Reviews 2020 Campbell IH, Campbell H Bipolar Disorder Mechanisms of Insulin Resistance, Mitochondrial Dysfunction and the Action of the Ketogenic Diet in Bipolar Disorder (opens in a new tab)

This review proposes that a ketogenic diet directly targets hyperinsulinemia and mitochondrial dysfunction in bipolar disorder, advocating for a mechanistic clinical trial.

Clinical Trials 2022 Calkin, et al. Bipolar Disorder Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (opens in a new tab)

A 26-week trial of 45 participants with treatment-resistant bipolar depression showed metformin-driven insulin resistance reversal significantly reduced depression and improved global function.

Case Series 2022 Danan A et al. Bipolar Disorder, Schizoaffective Disorder, Depression Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients (opens in a new tab)

A retrospective analysis of 28 psychiatric inpatients showed an adjunctive ketogenic diet significantly improved symptoms of refractory depression, psychosis, and metabolic health.

Showing 1–4 of 72 records

Looking for more resources?

MetPsy is a network designed for clinicians and researchers. Find additional science, strategies, and lived experience stories on our partner site, Metabolic Mind.

Go to Metabolic Mind

ORIGINS

A hundred years,and a family.

Metabolic psychiatry did not begin with a trial. It begins with ketogenic therapy in epilepsy, continues through early pilot work in serious mental illness, and reaches the present because families and clinicians kept asking the questions.

  • 1921

    Ketogenic therapy enters the clinic.

    Ketogenic diet established as a medical treatment for epilepsy at the Mayo Clinic.

  • 1965

    Mental illness comes into focus. 

    First ketogenic diet exploration for serious mental illness. 

  • 2000s-2020s

    Pilot studies, then trials. 

    Questions about the high prevalence of metabolic disorders among patients with mental illness.

    Early pilots report symptom and metabolic improvement. 

  • 2020-2021

    Baszucki family asks the question.

    2020
    Launch of the Baszucki Brain Research Fund to invest in bipolar disorder science, which quickly pivoted toward metabolic neuroscience and ketogenic interventions.

    2021 
    Baszucki Group is established with a mission that includes building the infrastructure for the emerging field of metabolic psychiatry.

  • 2026

    The field reaches milestones.

    Experts reach consensus on the use of ketogenic therapy for serious mental illness. 

    First RCTs of ketogenic therapy for psychosis and treatment-resistant depression.

    Additional RCTs underway.

NETWORK · FOR CLINICIANS, RESEARCHERS AND PARTNERS

Join your peers. Help
the field move.


Joining takes just a few moments and connects you to free training, resources, and opportunities to network with both experts in the field and individuals who are new to MetPsy.

Join the network